Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 5851 AL 5865

Precision prevention for neurodegenerative diseases: lessons learnt from Alzheimer's disease translated into perspectives for Parkinson's disease

Béchet S, Leonard M, Ademola E, Fritz JV, Krüger R.

J Neural Transm (Vienna). 2026 Feb;133(2):265-277. doi: 10.1007/s00702-025-03090-z. Epub 2025 Dec 26.

Non-Pharmacological and Non-Surgical Management of Parkinson's Disease: A Systematic Review of Clinical Practice Guidelines

Terrens AF, Taylor NF, Lewis A, Harding K, Morris ME.

Mov Disord Clin Pract. 2026 May;13(5):1147-1165. doi: 10.1002/mdc3.70453. Epub 2025 Dec 26.

Temporal Dynamics and Cross-Sectional and Longitudinal Factors Associated With Motor Reserve and Outcome in Patients With Parkinson Disease

Tsukita K, Kikuya A, Yoshimura K, Nakanishi E, Matsumoto R, Takahashi R.

Neurology. 2026 Jan 27;106(2):e214475. doi: 10.1212/WNL.0000000000214475. Epub 2025 Dec 26.

Lipid-based nanostructures in targeted management of neurological disorders: A comprehensive review

Guleria M, Kamble A, Upadhyay M, Sethi P, Patel MB, Malhan A, Rastogi S, Datta D, Singh S, Prajapati BG.

Int J Pharm. 2026 Feb 10;690:126530. doi: 10.1016/j.ijpharm.2025.126530. Epub 2025 Dec 24.

Comments on the article "Mortality rates for Parkinson's disease are increasing in Spain. An age-period-cohort and joinpoint analysis of mortality rates from 1981 to 2020"

Benito-León J, Benito-Rodríguez CM.

Neurologia (Engl Ed). 2026 Mar;41(2):101893. doi: 10.1016/j.nrleng.2025.101893. Epub 2025 Dec 24.

Immune involvement in neuropsychiatric disorders: Insights from single-cell transcriptomic studies

Takeda T, Toritsuka M, Tamakoshi H, Iwata N, Makinodan M.

Psychiatry Clin Neurosci. 2026 Apr;80(4):241-249. doi: 10.1111/pcn.70018. Epub 2025 Dec 27.

Synuclein and Mitochondrial Dysfunction: Regulating the Protein Import Complex toward PD Treatment?

Dash UK, Mahalakshmi R.

ACS Chem Neurosci. 2026 Jan 7;17(1):5-20. doi: 10.1021/acschemneuro.5c00323. Epub 2025 Dec 27.

The role of HMGB1 in central nervous system (CNS) diseases: mechanisms and therapeutic perspectives

Du O, Wu YJ, Li MY, Du JR.

Cytokine. 2026 Feb;198:157099. doi: 10.1016/j.cyto.2025.157099. Epub 2025 Dec 26.

Ultrasound for the assessment of muscle architecture in Parkinson's disease: A scoping review

Behraznia M, Ditroilo M, Smith T.

Clin Biomech (Bristol). 2026 Feb;132:106733. doi: 10.1016/j.clinbiomech.2025.106733. Epub 2025 Dec 19.

Neurodevelopmental origins of neurodegeneration: a lifespan perspective on brain vulnerability

Kopalli SR, Vadia N, Varma P, Mishra S, Joshi N, Bansal P, Al-Hasnaawei S, Chauhan AS, Jain H, Nathiya D, Devi A, Jayasingh Chellammal HS, Gupta P, Wal P, Koppula S.

Brain Res. 2026 Feb 15;1873:150134. doi: 10.1016/j.brainres.2025.150134. Epub 2025 Dec 26.

The Race to Salvage Glucocerebrosidase: Understanding Small-Molecule Therapies for GBA1-Associated Parkinsonism

Henderson MJ, Chen TC, Glasstetter LM, Chen Y, Marugan JJ, Sidransky E.

Mov Disord. 2026 Mar;41(3):596-602. doi: 10.1002/mds.70168. Epub 2025 Dec 29.

Delayed-onset parkinsonism after carbon monoxide poisoning: neuropsychological perspectives from a case report

Ingiardi M, Pini E, Laini V, Feder B, Magni E, Fagoni N, Pepe F.

Neurocase. 2026 Feb;32(1):3-12. doi: 10.1080/13554794.2025.2610945. Epub 2025 Dec 29.

Do sex differences in dementia with Lewy bodies arise from Alzheimer's disease biological profile?

Lange R, Aveneau C, Wallon D, Degos B, Obadia A, Hourregue C, Benisty S, Garcin B, Dumurgier J, Paquet C.

J Alzheimers Dis. 2026 Feb;109(4):1621-1624. doi: 10.1177/13872877251407708. Epub 2025 Dec 29.

Racial and Ethnic Diversity in Clinical Trials for Disease Modifying Drugs in Parkinson Disease: A Systematic Review & Meta-Analysis

Rodrigues FR, Bolner G, Ribeiro GBES, Koppanatham A, da Silva RV, Fearon C, Schumacher Schuh AF, Bayram E, Couto JBM, Ushe M, Di Luca DG.

Mov Disord Clin Pract. 2026 May;13(5):1295-1300. doi: 10.1002/mdc3.70482. Epub 2025 Dec 30.

Incretin-based therapy and Parkinson's disease risk among patients with type 2 diabetes: Retrospective cohort study and meta-analysis

Barer Y, Ast T, Chodick G, Twig G, Giladi N.

Parkinsonism Relat Disord. 2026 Feb;143:108171. doi: 10.1016/j.parkreldis.2025.108171. Epub 2025 Dec 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias